Insights

Global Expansion Opportunities Seqens has expanded its facilities to France and the United States, indicating a potential increase in production capacity and a strategic presence in key markets. This expansion opens up opportunities for new partnerships and customer acquisitions in these regions.

Exclusive Manufacturing Partnerships Seqens has signed exclusive manufacturing agreements with companies like Aether Industries and Biophytis SA for producing bio-based products and active compounds. Leveraging these partnerships, there is a possibility to explore joint sales strategies and collaborations to target a wider customer base.

Innovative R&D Investments Seqens announced a 'multi-million-dollar' R&D investment at its facility in Massachusetts. This investment in research and development signifies a commitment to innovation and developing cutting-edge products, presenting opportunities for launching new products and expanding market reach.

Market Share Consolidation By investing in building a plant to meet Europe's paracetamol needs, Seqens aims to capture a significant portion of the market share for this vital drug ingredient. This initiative creates potential opportunities for securing long-term contracts with pharmaceutical companies and distributors across Europe.

Acquisition by SK Capital Partners Seqens being acquired by SK Capital Partners presents opportunities for synergies with other companies under the same ownership. This acquisition can lead to cross-selling opportunities, shared distribution networks, and enhanced market presence, boosting sales and revenue.

Similar companies to SEQENS

SEQENS Tech Stack

SEQENS uses 8 technology products and services including Google Analytics, QlikView, Atex, and more. Explore SEQENS's tech stack below.

Google Analytics
Analytics
QlikView
Business Intelligence
Atex
Content Management System
Oracle
Enterprise
Engagez
Event Management
ADP
Human Resource Management System
Microsoft
Miscellaneous
Google Tag Manager
Tag Management

Media & News

SEQENS's Email Address Formats

SEQENS uses at least 1 format(s):

SEQENS Email Formats	Example	Percentage
First.Last@seqens.com	John.Doe@seqens.com	86%
FLast@seqens.com	JDoe@seqens.com	13%
FMiddleLast@seqens.com	JMichaelDoe@seqens.com	1%

Frequently Asked Questions

Where is SEQENS's headquarters located?

SEQENS's main headquarters is located at 21, Chemin de la Sauvegarde Écully, Auvergne-Rhône-Alpes 69130 FR. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is SEQENS's official website and social media links?

SEQENS's official website is seqens.com and has social profiles on LinkedIn.

How much revenue does SEQENS generate?

As of September 2024, SEQENS's annual revenue reached $750M.

What is SEQENS's NAICS code?

SEQENS's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does SEQENS have currently?

As of September 2024, SEQENS has approximately 1.3K employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Financial Officer And Chief Operations Officer: P. S.Chief Compliance Officer: A. B.Chief Procurement Officer: C. D.. Explore SEQENS's employee directory with LeadIQ.

What industry does SEQENS belong to?

SEQENS operates in the Pharmaceutical Manufacturing industry.

What technology does SEQENS use?

SEQENS's tech stack includes Google AnalyticsQlikViewAtexOracleEngagezADPMicrosoftGoogle Tag Manager.

What is SEQENS's email format?

SEQENS's email format typically follows the pattern of . Find more SEQENS email formats with LeadIQ.

When was SEQENS founded?

SEQENS was founded in 2003.

SEQENS

Pharmaceutical ManufacturingAuvergne-Rhône-Alpes, France1001-5000 Employees

SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. 

The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.

SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.

Company Overview

Headquarters: 21, Chemin de la Sauvegarde Écully, Auvergne-Rhône-Alpes 69130 FR
Website: seqens.com
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 2003
Employees: 1001-5000

Media & News

Funding & Financials

$100M$1B
SEQENS's revenue is in the range of $100M$1B

Funding & Financials

$100M$1B
SEQENS's revenue is in the range of $100M$1B

Company Leadership

P. S.
Chief Financial Officer And Chief Operations Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. B.
Chief Compliance Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. D.
Chief Procurement Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. D. R.
Chief Financial Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. V.
Chief Of Staff - R&d
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

C. D.
Chief Procurement Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. L.
Owner
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. D. R.
Chief Financial Officer
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
P. C.
Ceo
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
V. M.
Directeur Financier / Group Cfo
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for SEQENS and Millions of Other Companies
Sign up for full access to SEQENS information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to SEQENS

Vertellus

BASF

Roche

Dow

Novasep

Evonik

Lonza

Sumitomo Chemical

Novartis

Mintek

SEQENS Tech Stack

Media & News

Aether Industries partners with Seqens group.

Seqens group partners with Holcim.

Seqens group partners with Univar.

Biophytis SA partners with Seqens group.

Seqens group expands facilities to France.

SK Capital Partners LP acquired Seqens group on Apr 8th '21.

Seqens group expanded facilities to Massachusetts, United States on Feb 28th '22.

SEQENS's Email Address Formats

Frequently Asked Questions

Where is SEQENS's headquarters located?

What is SEQENS's official website and social media links?

How much revenue does SEQENS generate?

What is SEQENS's NAICS code?

How many employees does SEQENS have currently?

What industry does SEQENS belong to?

What technology does SEQENS use?

What is SEQENS's email format?

When was SEQENS founded?

SEQENS

Company Overview

Media & News

Aether Industries partners with Seqens group.

Seqens group partners with Holcim.

Seqens group partners with Univar.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?